John B. Payne - 16 Oct 2024 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
President and CEO, Director
Signature
/s/ John B. Payne
Issuer symbol
ZIVO
Transactions as of
16 Oct 2024
Net transactions value
+$109,961
Form type
4
Filing time
16 Oct 2024, 16:07:29 UTC
Previous filing
06 Jun 2024
Next filing
28 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIVO Common Stock Purchase $99,966 +6,343 +405% $15.76 7,909 16 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Common Stock Warrant Purchase $9,995 +634 $15.76 634 16 Oct 2024 Common Stock 634 $15.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.